AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7998486 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nimodipine, 2 mg per hour for 7 days
Number of subjects: 268
Study 7998486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study 3194342 — intervention group
Group type: EXPERIMENTAL
Intervention: roxithromycin (150 mg b.i.d.)
Number of subjects: 21
Study 3194342 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21
Study 30358242 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine treatment (12 weeks)
Number of subjects: 46
Study 30358242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 28762072 — intervention group
Group type: EXPERIMENTAL
Intervention: D-amphetamine (20 mg)
Number of subjects: 70
Study 28762072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 26218228 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct treatment (Lidcombe Program)
Number of subjects: 199
Study 26218228 — intervention group
Group type: COMPARATOR
Intervention: Indirect treatment (RESTART-DCM treatment)
Number of subjects: 199
Study 23054851 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil massage along with standard care of low birth weight
Number of subjects: 48
Study 23054851 — intervention group
Group type: COMPARATOR
Intervention: Standard care of low birth weight without massage
Number of subjects: 48
Study 20878861 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary quality of life (MQOL) intervention (n=30)
Number of subjects: 57
Study 20878861 — intervention group
Group type: COMPARATOR
Intervention: Wait list control (n=27)
Number of subjects: 57
Study 18801158 — intervention group
Group type: EXPERIMENTAL
Intervention: Community promotion in addition to IPTp-SP (Intervention A)
Number of subjects: 0
Study 18801158 — intervention group
Group type: COMPARATOR
Intervention: Weekly chloroquine (Control)
Number of subjects: 0
Study 18801158 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTp-SP (Intervention B)
Number of subjects: 0
Study 17146393 — intervention group
Group type: EXPERIMENTAL
Intervention: GJB2 group (individuals with biallelic GJB2 mutations)
Number of subjects: 53
Study 17146393 — intervention group
Group type: EXPERIMENTAL
Intervention: GJB2 group
Number of subjects: 53
Study 17146393 — intervention group
Group type: COMPARATOR
Intervention: Normally hearing individuals (control group)
Number of subjects: 53
Study 12665988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling (CYC)
Number of subjects: 7
Study 12665988 — intervention group
Group type: EXPERIMENTAL
Intervention: Running (RUN)
Number of subjects: 7
Study 12665988 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 7
Study 11052438 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane, 0 to 1% plus fentanyl, 0.1 microg/kg/min
Number of subjects: 50
Study 11052438 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine, 0 to 5 mg/kg/h plus fentanyl, 0.1 microg/kg/min
Number of subjects: 50
Study 9055774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound detection of foreign bodies
Number of subjects: 80
Study 9055774 — intervention group
Group type: COMPARATOR
Intervention: Control punctures (no foreign bodies)
Number of subjects: 80
Study 8140562 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline (S) 10 mg/day
Number of subjects: 93
Study 8140562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 3315778 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg daily for 3 days
Number of subjects: 60
Study 3315778 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg in a single administration
Number of subjects: 60
Study 3315778 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg in a single administration
Number of subjects: 60
Study 29325772 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate carbohydrates diet
Number of subjects: 284
Study 29325772 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet
Number of subjects: 284
Study 26973701 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline supplementation (310 mg choline bitartrate twice daily for 6 weeks)
Number of subjects: 30
Study 26973701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 24322628 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperpronation (HP)
Number of subjects: 115
Study 24322628 — intervention group
Group type: EXPERIMENTAL
Intervention: Supination-Flexion (SF)
Number of subjects: 115
Study 24322628 — intervention group
Group type: EXPERIMENTAL
Intervention: Both maneuvers
Number of subjects: 115
Study 24322628 — intervention group
Group type: COMPARATOR
Intervention: Prior manipulation
Number of subjects: 115
Study 22503380 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 216
Study 22503380 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 216
Study 19439742 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine-dexamethasone group
Number of subjects: 800
Study 19439742 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine group
Number of subjects: 800
Study 19439742 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone group
Number of subjects: 800
Study 19439742 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 800
Study 17954513 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (standardised protocol management with financial incentives)
Number of subjects: 951
Study 17954513 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal management without financial incentives)
Number of subjects: 951
Study 17954513 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 951
Study 17954513 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (patients with positive malaria slides)
Number of subjects: 951
Study 16353868 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoton in combination with ischemic training
Number of subjects: 86
Study 16353868 — intervention group
Group type: COMPARATOR
Intervention: Standard antianginal therapy
Number of subjects: 86
Study 12370998 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of patients with lung disease caused by RGM
Number of subjects: 0
Study 9657222 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-liquid extraction (LLE)
Number of subjects: 0
Study 9657222 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated on-line solid-phase extraction (on-line SPE)
Number of subjects: 0
Study 7655128 — intervention group
Group type: EXPERIMENTAL
Intervention: ivpb (intravenous piggyback) infusion of tobramycin sulfate 2 mg/kg at 100 mL/h for 30 minutes
Number of subjects: 8
Study 7655128 — intervention group
Group type: EXPERIMENTAL
Intervention: slow CRIS (controlled-release infusion system) using a 20-mL vial at 60 mL/h for 1 hour
Number of subjects: 8
Study 7655128 — intervention group
Group type: EXPERIMENTAL
Intervention: fast CRIS using a 20-mL vial at 120 mL/h for 1 hour
Number of subjects: 8
Study 2247914 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 111
Study 2247914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 65606 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose hydrolysed milk
Number of subjects: 35
Study 65606 — intervention group
Group type: COMPARATOR
Intervention: Normal milk
Number of subjects: 35
Study 30854751 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral rTMS (low-frequency 1 Hz right DLPFC followed by high-frequency 10 Hz left DLPFC)
Number of subjects: 43
Study 30854751 — intervention group
Group type: COMPARATOR
Intervention: Unilateral HFL rTMS
Number of subjects: 43
Study 30854751 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 43
Study 28528015 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behavior therapy (CBT)
Number of subjects: 158
Study 28528015 — intervention group
Group type: COMPARATOR
Intervention: Behavioral stress management (BSM)
Number of subjects: 158
Study 24801119 — intervention group
Group type: EXPERIMENTAL
Intervention: MiStent absorbable polymer sirolimus‐eluting stent (APSES)
Number of subjects: 184
Study 24801119 — intervention group
Group type: COMPARATOR
Intervention: Zotarolimus‐eluting stent (ZES)
Number of subjects: 184
Study 24801119 — intervention group
Group type: EXPERIMENTAL
Intervention: Both stents
Number of subjects: 184
Study 23901280 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dairy (one serving/day each of 1% fluid milk, low-fat cheese, and low-fat yogurt)
Number of subjects: 62
Study 23901280 — intervention group
Group type: COMPARATOR
Intervention: Nondairy products (one serving/day each of apple juice, pretzels, and cereal bar)
Number of subjects: 62
Study 23901280 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dairy
Number of subjects: 62
Study 23901280 — intervention group
Group type: COMPARATOR
Intervention: Nondairy products
Number of subjects: 62
Study 21522030 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV risk reduction program
Number of subjects: 548
Study 21522030 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic disadvantage measures (percentage of years in the United States)
Number of subjects: 548
Study 21522030 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic disadvantage measures (education)
Number of subjects: 548
Study 20053240 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) delivered by a computer or therapist
Number of subjects: 533
Study 20053240 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist BI
Number of subjects: 533
Study 20053240 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer BI
Number of subjects: 533
Study 20053240 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 533
Study 16954552 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET
Number of subjects: 131
Study 15737849 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 360
Study 15737849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 12738896 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for appropriate reasons
Number of subjects: 2124
Study 12738896 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for uncertain reasons
Number of subjects: 2124
Study 12738896 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for inappropriate reasons
Number of subjects: 2124
Study 12738896 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy in symptomatic patients
Number of subjects: 2124
Study 12738896 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy in asymptomatic patients
Number of subjects: 2124
Study 12738896 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy in patients having combined carotid and coronary artery bypass graft surgery
Number of subjects: 2124
Study 12738896 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy in asymptomatic patients with high comorbidity
Number of subjects: 2124
Study 10430109 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg)
Number of subjects: 30
Study 10430109 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (1000 mg)
Number of subjects: 30
Study 10430109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7565947 — intervention group
Group type: EXPERIMENTAL
Intervention: Fialuridine at a dose of either 0.10 or 0.25 mg per kilogram of body weight per day for 24 weeks
Number of subjects: 15
Study 7565947 — intervention group
Group type: EXPERIMENTAL
Intervention: Fialuridine
Number of subjects: 15
Study 2164771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 2164771 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 400 mg at bedtime
Number of subjects: 302
Study 2164771 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (50 mg qds)
Number of subjects: 302
Study 2164771 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSO (500 mg qds)
Number of subjects: 302
Study 7028045 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.6‐benzo‐alpha‐pyron + 3',4',7‐tris‐(hydroxy‐ethyl)‐rutin (coumarin + troxerutin, Venalot) at 1 mg/kg/d related to the coumarin content
Number of subjects: 560
Study 7028045 — intervention group
Group type: COMPARATOR
Intervention: Coumarin and troxerutin applied separately
Number of subjects: 560
Study 31150552 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia-associated SNPs
Number of subjects: 105
Study 31150552 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective allele SNPs
Number of subjects: 105
Study 31155870 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum-blossom needle tapping plus moxibustion
Number of subjects: 60
Study 31155870 — intervention group
Group type: COMPARATOR
Intervention: Pelvic muscular exercise and passive intermittent urethral catheterization (Control)
Number of subjects: 60
Study 28209607 — intervention group
Group type: EXPERIMENTAL
Intervention: IY Autistic Spectrum and Language Delays (IY‐ASLD) parent programme
Number of subjects: 72
Study 28209607 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 72
Study 26181467 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-enriched indoor light (280 lux)
Number of subjects: 29
Study 26181467 — intervention group
Group type: COMPARATOR
Intervention: Blue-suppressed indoor light (240 lux)
Number of subjects: 29
Study 26181467 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-enriched light exposure
Number of subjects: 29
Study 26181467 — intervention group
Group type: COMPARATOR
Intervention: Baseline PSQI for females
Number of subjects: 29
Study 26181467 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective grading of indoor light quality
Number of subjects: 29
Study 23494579 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole egg consumption (3 eggs per day)
Number of subjects: 37
Study 23494579 — intervention group
Group type: COMPARATOR
Intervention: Yolk-free egg substitute
Number of subjects: 37
Study 21995983 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 152
Study 21995983 — intervention group
Group type: COMPARATOR
Intervention: Argon laser trabeculoplasty (ALT)
Number of subjects: 152
Study 18319422 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical binomial hierarchical Bayesian model
Number of subjects: 0
Study 17192686 — intervention group
Group type: EXPERIMENTAL
Intervention: VBP with mitomycin C
Number of subjects: 30
Study 17192686 — intervention group
Group type: COMPARATOR
Intervention: VBP
Number of subjects: 30
Study 14571187 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated Mycobacterium vaccae (MV) vaccine
Number of subjects: 39
Study 14571187 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine (CV)
Number of subjects: 39
Study 10730042 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaning newborn infants with coconut oil
Number of subjects: 227
Study 10730042 — intervention group
Group type: COMPARATOR
Intervention: Not being placed under radiant warmer before cleaning
Number of subjects: 227
Study 10730042 — intervention group
Group type: COMPARATOR
Intervention: Lower labour room temperature
Number of subjects: 227
Study 10730042 — intervention group
Group type: COMPARATOR
Intervention: Lower pre-cleaning body temperature
Number of subjects: 227
Study 10730042 — intervention group
Group type: COMPARATOR
Intervention: Longer duration of cleaning
Number of subjects: 227
Study 21594407 — intervention group
Group type: EXPERIMENTAL
Intervention: Peoscopy and treatment of male partners, condom use for one year (Group A, n=64)
Number of subjects: 246
Study 21594407 — intervention group
Group type: EXPERIMENTAL
Intervention: No peoscopy, no treatment of male partners, condom use for one year (Group B, n=79)
Number of subjects: 246
Study 21594407 — intervention group
Group type: EXPERIMENTAL
Intervention: Peoscopy and treatment of male partners, no condom use (Group C, n=40)
Number of subjects: 246
Study 21594407 — intervention group
Group type: COMPARATOR
Intervention: No peoscopy, no treatment of male partners, no condom use (Group D, n=63)
Number of subjects: 246
Study 1598311 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human colony-stimulating factors (CSFs) including Granulocyte CSF and Granulocyte-macrophage CSF
Number of subjects: 0
Study 6379319 — intervention group
Group type: EXPERIMENTAL
Intervention: Methenamine mandelate
Number of subjects: 39
Study 6379319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 30253723 — intervention group
Group type: EXPERIMENTAL
Intervention: Affirmative consent policy emphasizing the threat of punishment
Number of subjects: 0
Study 30253723 — intervention group
Group type: EXPERIMENTAL
Intervention: Affirmative consent policy emphasizing a normative/moral message
Number of subjects: 0
Study 30253723 — intervention group
Group type: COMPARATOR
Intervention: Ergonomic workstation policy
Number of subjects: 0
Study 27529226 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavonoid‐rich herbal preparation (500 mg)
Number of subjects: 157
Study 24619793 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g/m2 glutathione
Number of subjects: 185
Study 24619793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 20626402 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/20 mg (EZE/SIMVA)
Number of subjects: 618
Study 20626402 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg (ROSUVA)
Number of subjects: 618
Study 20626402 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/20 mg (EZE/SIMVA) in patients with T2DM
Number of subjects: 618
Study 20626402 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/20 mg (EZE/SIMVA) in patients without T2DM
Number of subjects: 618
Study 20346243 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D volumetric ultrasonography
Number of subjects: 2
Study 20346243 — intervention group
Group type: COMPARATOR
Intervention: 2D real-time ultrasonography
Number of subjects: 2
Study 18441447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control (n=155)
Number of subjects: 221
Study 18441447 — intervention group
Group type: COMPARATOR
Intervention: Rate control (n=66)
Number of subjects: 221
Study 16192765 — intervention group
Group type: EXPERIMENTAL
Intervention: AQUAVAN Injection (AQ) at doses of 5, 10, 15, 20, 25, or 30 mg/kg
Number of subjects: 36
Study 16192765 — intervention group
Group type: EXPERIMENTAL
Intervention: AQUAVAN Injection (AQ)
Number of subjects: 36
Study 16192765 — intervention group
Group type: COMPARATOR
Intervention: PropofolD (50 mg/min)
Number of subjects: 36
Study 16192765 — intervention group
Group type: COMPARATOR
Intervention: PropofolD
Number of subjects: 36
Study 16192765 — intervention group
Group type: EXPERIMENTAL
Intervention: AQUAVAN Injection (AQ) and PropofolD
Number of subjects: 36
Study 12548534 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 19
Study 12548534 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal IL-2 production)
Number of subjects: 19
Study 12103264 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BiV) in patients with sinus rhythm (SR)
Number of subjects: 131
Study 12103264 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BiV) in patients with atrial fibrillation (AF)
Number of subjects: 131
Study 10411363 — intervention group
Group type: EXPERIMENTAL
Intervention: Zofenopril (ACE inhibitor) given within 24 hours of symptom onset
Number of subjects: 1441
Study 7586247 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (20 mg, 40 mg, 1 mg/kg, 2 mg/kg)
Number of subjects: 0
Study 7586247 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin (7500 ICU, 10,000 ICU, 225 ICU/kg, 450 ICU/kg)
Number of subjects: 0
Study 2138449 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 16
Study 2138449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (fractionated coconut oil)
Number of subjects: 16
Study 7247630 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 15
Study 7247630 — intervention group
Group type: COMPARATOR
Intervention: Thiothixene
Number of subjects: 15
Study 31299257 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoRings
Number of subjects: 562
Study 31299257 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 562
Study 31233395 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ileocaecal resection
Number of subjects: 143
Study 31233395 — intervention group
Group type: COMPARATOR
Intervention: Infliximab
Number of subjects: 143
Study 28728603 — intervention group
Group type: EXPERIMENTAL
Intervention: Social pressure covering letter (n=2223)
Number of subjects: 4447
Study 28728603 — intervention group
Group type: COMPARATOR
Intervention: Control covering letter (n=2224)
Number of subjects: 4447
Study 25586754 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 45
Study 25586754 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 45
Study 25586754 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (CBT + Sertraline)
Number of subjects: 45
Study 23425352 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition-focused intervention (CA)
Number of subjects: 0
Study 23425352 — intervention group
Group type: COMPARATOR
Intervention: General education (control)
Number of subjects: 0
Study 21073983 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg oral codeine
Number of subjects: 15
Study 21073983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 19197541 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 72
Study 19197541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 72
Study 19197541 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine and Fluvoxamine
Number of subjects: 72
Study 17539886 — intervention group
Group type: EXPERIMENTAL
Intervention: Young maternal age (<=18 years)
Number of subjects: 1393
Study 17539886 — intervention group
Group type: EXPERIMENTAL
Intervention: Each year of increasing maternal age
Number of subjects: 1393